Tang Suoqin

Spécialisation: Pediatric hematologist/oncologist
33 années d'expérience
Espace de travail: Chine, Pékin, Beijing Jingdu Children’s Hospital
As a specialist at the clinic, Dr. Tang Suoqin is a Distinguished Professor and Senior Consultant in the Department of Hematology and Oncology at Beijing Jingdu Children’s Hospital. He has over 30 years of clinical and academic leadership focused on high-risk neuroblastoma and refractory pediatric solid tumors. His profile includes authorship/feature in a Nature Communications 2024 Phase I/II trial titled “A Phase I/II Trial.” He also has ongoing work on AI-driven precision oncology platforms aimed at improving access to advanced therapies across China.
Dr. Tang Suoqin is a specialist at the clinic and Senior Consultant/Distinguished Professor in the Department of Hematology and Oncology at Beijing Jingdu Children’s Hospital. With over 30 years of clinical and academic leadership, he focuses on high-risk neuroblastoma and refractory pediatric solid tumors. His differentiator includes involvement in a Nature Communications 2024 Phase I/II trial (“A Phase I/II Trial”) and ongoing work on AI-driven precision oncology platforms to broaden access to therapies.

Services du médecin

Où en sommes-nous ?

1 de 3

Les détails sur ce médecin sont exhaustifs et clairs

Fortement en désaccord

Fortement d’accord

Qualifications

Dr. Tang Suoqin’s pediatric oncology work spans both clinical treatment and translational research, including a Phase I/II trial presented in Nature Communications (2024) titled “A Phase I/II Trial.” As a specialist at the clinic, he is a Distinguished Professor and Senior Consultant in the Department of Hematology and Oncology at Beijing Jingdu Children’s Hospital. His profile describes more than 30 years of clinical and academic leadership focused on high-risk neuroblastoma and refractory pediatric solid tumors. His career also includes institutional leadership experience, including serving as Director of Pediatrics at the People’s Liberation Army General Hospital (PLAGH) before joining the clinic in the 2010s.

Work experience

Distinguished Professor and Senior Consultant, Department of Hematology and Oncology — Beijing Jingdu Children’s Hospital.
Director of Pediatrics — People’s Liberation Army General Hospital (PLAGH).

Clinical focus and techniques

Dr. Tang Suoqin’s clinical scope is pediatric oncology, with a focus on difficult-to-treat solid tumors where protocol-level decisions can affect outcomes.

Complex treatment for neuroblastoma.
Targeted therapy (described as part of his neuroblastoma treatment work).
Immunotherapy work is referenced as part of his broader pediatric oncology framework.

Academic output

Nature Communications (2024) — Phase I/II trial titled “A Phase I/II Trial.”

Courses and advanced training

No named courses are specified in the provided materials.

Awards and recognition

His profile highlights research and healthcare advocacy rather than named awards.

For families seeking pediatric oncology consultation, the clinic supports multidisciplinary evaluation and protocol-driven planning. Dr. Tang Suoqin’s focus includes high-risk neuroblastoma and refractory pediatric solid tumors, and his ongoing work aims to expand access to advanced therapies through AI-driven precision oncology platforms.